Search

Sophia S. Chen

Examiner (ID: 12715, Phone: (571)272-2133 , Office: P/2852 )

Most Active Art Unit
2852
Art Unit(s)
2809, 2105, 2852
Total Applications
3640
Issued Applications
3462
Pending Applications
93
Abandoned Applications
111

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9462822 [patent_doc_number] => 20140127249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'INFLUENZA VIRUS MUTANTS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 14/128415 [patent_app_country] => US [patent_app_date] => 2012-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 31574 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128415 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/128415
Influenza virus mutants and uses therefor Jun 20, 2012 Issued
Array ( [id] => 9817188 [patent_doc_number] => 08926971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-06 [patent_title] => 'Humanized anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 13/528407 [patent_app_country] => US [patent_app_date] => 2012-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 65 [patent_no_of_words] => 35259 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13528407 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/528407
Humanized anti-CCR2 antibodies and methods of use therefor Jun 19, 2012 Issued
Array ( [id] => 9596770 [patent_doc_number] => 20140193450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-10 [patent_title] => 'PEPTIDE CARRIER FUSION PROTEINS AS ALLERGY VACCINES' [patent_app_type] => utility [patent_app_number] => 14/124925 [patent_app_country] => US [patent_app_date] => 2012-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 29072 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124925 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/124925
Peptide carrier fusion proteins as allergy vaccines Jun 10, 2012 Issued
Array ( [id] => 9691301 [patent_doc_number] => 08821891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Live attenuated rotavirus vaccine for oral administration' [patent_app_type] => utility [patent_app_number] => 13/486039 [patent_app_country] => US [patent_app_date] => 2012-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 32293 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13486039 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/486039
Live attenuated rotavirus vaccine for oral administration May 31, 2012 Issued
Array ( [id] => 11304800 [patent_doc_number] => 09512185 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-06 [patent_title] => 'Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof' [patent_app_type] => utility [patent_app_number] => 14/123305 [patent_app_country] => US [patent_app_date] => 2012-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 38 [patent_no_of_words] => 16584 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123305 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/123305
Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof May 31, 2012 Issued
Array ( [id] => 11304798 [patent_doc_number] => 09512184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-06 [patent_title] => 'Hepatitis C virus particles, vaccines, compositions and methods related thereto' [patent_app_type] => utility [patent_app_number] => 14/118855 [patent_app_country] => US [patent_app_date] => 2012-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 14644 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118855 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/118855
Hepatitis C virus particles, vaccines, compositions and methods related thereto May 17, 2012 Issued
Array ( [id] => 8464717 [patent_doc_number] => 20120269885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'Vaccine for Modulating Between T1 and T2 Immune Responses' [patent_app_type] => utility [patent_app_number] => 13/462356 [patent_app_country] => US [patent_app_date] => 2012-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8764 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462356 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/462356
Vaccine for Modulating Between T1 and T2 Immune Responses May 1, 2012 Abandoned
Array ( [id] => 8464716 [patent_doc_number] => 20120269884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'Vaccine for Modulating Between T1 and T2 Immune Responses' [patent_app_type] => utility [patent_app_number] => 13/462314 [patent_app_country] => US [patent_app_date] => 2012-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8763 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462314 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/462314
Vaccine for modulating between T1 and T2 immune responses May 1, 2012 Issued
Array ( [id] => 10863457 [patent_doc_number] => 08889147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'DNA vaccine against multitypes of avian influenza viruses and influenza virus-like particles comprising adjuvant-fused M2 protein' [patent_app_type] => utility [patent_app_number] => 13/449654 [patent_app_country] => US [patent_app_date] => 2012-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 20 [patent_no_of_words] => 7596 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13449654 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/449654
DNA vaccine against multitypes of avian influenza viruses and influenza virus-like particles comprising adjuvant-fused M2 protein Apr 17, 2012 Issued
Array ( [id] => 9435047 [patent_doc_number] => 20140112954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-24 [patent_title] => 'METHOD FOR PREPARING HBV VACCINE COMPRISING ALUMINUM ADJUVANT' [patent_app_type] => utility [patent_app_number] => 14/117937 [patent_app_country] => US [patent_app_date] => 2012-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5327 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117937 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/117937
METHOD FOR PREPARING HBV VACCINE COMPRISING ALUMINUM ADJUVANT Apr 17, 2012 Abandoned
Array ( [id] => 11583131 [patent_doc_number] => 09637758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-02 [patent_title] => 'Modified Sendai virus vaccine and imaging vector' [patent_app_type] => utility [patent_app_number] => 14/113769 [patent_app_country] => US [patent_app_date] => 2012-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 26 [patent_no_of_words] => 30031 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113769 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/113769
Modified Sendai virus vaccine and imaging vector Apr 12, 2012 Issued
Array ( [id] => 9408083 [patent_doc_number] => 20140099335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'DNA VACCINE' [patent_app_type] => utility [patent_app_number] => 14/111699 [patent_app_country] => US [patent_app_date] => 2012-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9447 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111699 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/111699
DNA vaccine Apr 12, 2012 Issued
Array ( [id] => 9476741 [patent_doc_number] => 20140134204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'METHODS OF IMPROVING VACCINE IMMUNOGENICITY' [patent_app_type] => utility [patent_app_number] => 14/110101 [patent_app_country] => US [patent_app_date] => 2012-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21580 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110101 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/110101
Methods of improving vaccine immunogenicity Apr 3, 2012 Issued
Array ( [id] => 9482774 [patent_doc_number] => 08728723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-20 [patent_title] => 'Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism' [patent_app_type] => utility [patent_app_number] => 13/435325 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 17444 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13435325 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/435325
Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism Mar 29, 2012 Issued
Array ( [id] => 9476743 [patent_doc_number] => 20140134206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'INFLAMMATION AND IMMUNITY TREATMENTS' [patent_app_type] => utility [patent_app_number] => 14/008995 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9929 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008995 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/008995
Inflammation and immunity treatments Mar 29, 2012 Issued
Array ( [id] => 8885049 [patent_doc_number] => 20130158233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'METHOD FOR SIMULTANEOUSLY DETECTING AN ANTIGEN OF, AND AN ANTIBODY, AGAINST, AN INFECTIOUS MICROORGANISM' [patent_app_type] => utility [patent_app_number] => 13/435381 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17378 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13435381 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/435381
Method for simultaneously detecting an antigen of, and an antibody, against, an infectious microorganism Mar 29, 2012 Issued
Array ( [id] => 8453163 [patent_doc_number] => 20120264109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'LYMPHOCYTE ANALYSIS FOR MONITORING THE PROGRESSION OF IMMUNODEFICIENCY VIRUS' [patent_app_type] => utility [patent_app_number] => 13/432542 [patent_app_country] => US [patent_app_date] => 2012-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4023 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13432542 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/432542
LYMPHOCYTE ANALYSIS FOR MONITORING THE PROGRESSION OF IMMUNODEFICIENCY VIRUS Mar 27, 2012 Abandoned
Array ( [id] => 9197614 [patent_doc_number] => 20130336929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'METHODS AND CELLS FOR IDENTIFYING RIG-I PATHWAY REGULATORS' [patent_app_type] => utility [patent_app_number] => 14/001472 [patent_app_country] => US [patent_app_date] => 2012-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17815 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001472 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/001472
Methods and cells for identifying RIG-I pathway regulators Feb 22, 2012 Issued
Array ( [id] => 11794129 [patent_doc_number] => 09403879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same' [patent_app_type] => utility [patent_app_number] => 13/984771 [patent_app_country] => US [patent_app_date] => 2012-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 20 [patent_no_of_words] => 14475 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984771 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/984771
Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same Feb 12, 2012 Issued
Array ( [id] => 10850527 [patent_doc_number] => 08877205 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'Yeast-based therapeutic for chronic hepatitis B infection' [patent_app_type] => utility [patent_app_number] => 13/984888 [patent_app_country] => US [patent_app_date] => 2012-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 42 [patent_no_of_words] => 96296 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984888 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/984888
Yeast-based therapeutic for chronic hepatitis B infection Feb 8, 2012 Issued
Menu